ABOS
Acumen Pharmaceuticals, Inc.—15-min delayed · EOD close3.10 +6.16% upas of 2026-09-02mkt cap $224M
Biological Products, (No Diagnostic Substances) · SIC 2836 · CIK 0001576885
Who’s trading ABOS
Corporate insiders on Form 4, House members under the STOCK Act, and the funds reporting a position in their 13F.
Corporate insiders
none
no Form 4 filings on record
Congress
none
no disclosed trades
Funds holding
2 filers
$1.9M reported
The counts above are free. Who they are, and what each of them traded, is part of Pro — see what it includes.
Form 4 insider trades are exact and filed within two business days. Congressional figures are range midpoints disclosed up to 45 days after the trade, and 13F positions are a quarter-end snapshot. All three are a record of what was disclosed, not a signal.